Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Reimbursement With Average Sales Price Formula Is “Best” – Scully

Executive Summary

A modified average sales price formula is the best current legislative approach to reforming Medicare payments for covered drugs, Centers for Medicare & Medicaid Services Administrator Tom Scully said

You may also be interested in...



House AWP Reform Plan Could Transition From ASP To Private Bidding

The House is interested in an AWP reform approach that would begin by using an "average sales price" then transition to competitive bidding

House AWP Reform Plan Could Transition From ASP To Private Bidding

The House is interested in an AWP reform approach that would begin by using an "average sales price" then transition to competitive bidding

AWP “Spread” Estimated At 40% In CMS Outpatient Bundle Rule

CMS' current estimate of the "spread" between published average wholesale prices and actual acquisition costs for pharmaceuticals covered by Medicare is approximately 40%

Related Content

UsernamePublicRestriction

Register

PS039498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel